DTX1泛素化降解DEFB1对乙肝感染的负向调节机制
批准号:
81970521
项目类别:
面上项目
资助金额:
50.0 万元
负责人:
刘宏鸣
依托单位:
学科分类:
炎性及感染性肝病
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
刘宏鸣
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
乙型肝炎病毒(HBV)感染是一个严重的全球性健康问题,但HBV感染及其导致的慢性肝炎的发生机制仍不明确。DTX1是一种E3泛素连接酶,在调节宿主T细胞与乙肝病毒免疫反应机制中起着至关重要的作用。抗菌肽DEFB1是DTX1的泛素化底物之一,但其在乙肝感染中的作用和相关机制尚未明确。在我们的前期研究中发现DTX1、DEFB1基因水平在慢性乙肝病人的肝组织中表达显著升高,而DEFB1蛋白水平降低,且HBV患者DEFB1蛋白水平与DTX1负相关,因此,我们推测,DTX1可能通过泛素化降解DEFB1从而调控HBV感染。本研究拟以DTX1基因敲除小鼠、L02和HepG2.2.15细胞系为研究对象,通过构建HBV感染小鼠模型和细胞模型,阐明DTX1和DEFB1在HBV感染中的作用,并探索DTX1泛素化降解DEFB1的分子机制。本研究将帮助我们为慢性乙肝的治疗寻找新的靶向分子。
英文摘要
Infection of hepatitis B virus is a serious global health issue, but the mechanisms of HBV infection and hepatitis occurrence still remain vague. DTX1 is an E3 ubiquitin ligase, which plays important roles in regulating T cell function and HBV immunity. DEFB1 is one of the substrates of DTX1-mediated ubiquitination, but its role in HBV infection remains unknown. In our previous study we found that the expression levels of DTX1 and DEFB1 genes were significantly elevated in HBV-infected patients, whereas the protein level of DEFB1 significantly dropped. Moreover, the protein levels of DEFB1 in HBV-infected patients were negatively correlated with that of DTX1. Taken together, we speculate that DTX1 may regulate HBV infection via mediating the ubiquitination and degradation of DEFB1. In this study, DTX1 knockout mice, L02 and HepG2.2.15 cells will be used to illustrate the role of DTX1 and DEFB1 in HBV infection, molecular biology experiments will be conducted to explore the mechanism of DEFB1 ubiquitination mediated by DTX1. This study will help us to look for the novel therapeutic target to chronic HBV hepatitis.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1002/1873-3468.14696
发表时间:2023-07-18
期刊:FEBS LETTERS
影响因子:3.5
作者:Feng,Yi;Yao,Shu;Liu,Hongming
通讯作者:Liu,Hongming
Deltex1基因单体型与乙肝疫苗接种后免疫应答差异性的关联研究
- 批准号:81172739
- 项目类别:面上项目
- 资助金额:60.0万元
- 批准年份:2011
- 负责人:刘宏鸣
- 依托单位:
国内基金
海外基金















{{item.name}}会员


